Lebrikizumab is efficacious and safe for patients with skin of color and eczema: Study

For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study published online July 15 in the American Journal of Clinical Dermatology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup